End Stage Renal Disease on Dialysis: Clinical Trials

70 trials for End Stage Renal Disease on Dialysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 20 unknown, 11 recruiting, 5 active not recruiting. 34 Not applicable, 8 Phase 4, 7 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable34Completed 16, Unknown 11, Recruiting 4, Active not recruiting 2, Not yet recruiting 1
Phase 48Active not recruiting 2, Completed 2, Recruiting 2, Not yet recruiting 1, Terminated 1
Phase 27Recruiting 3, Active not recruiting 1, Completed 1, Not yet recruiting 1, Unknown 1
Phase 32Completed 1, Not yet recruiting 1
Phase 11Recruiting 1

Follow End Stage Renal Disease on Dialysis: new trials by email Literature Review of End Stage Renal Disease on Dialysis trials Research Report on End Stage Renal Disease on Dialysis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Nalfurafine for Chronic Kidney Disease-Associated Pruritus in Twice-Weekly Hemodialysis Patients: A Randomized Controlled Trial
Nalfurafine Hydrochloride, plasebo - Chronic Kidney Disease Associated Pruritus, End Stage Renal Disease on Dialysis
Phase 4Not yet recruitingUniversitas Indonesia362026-08-172026-08-17
VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery
Virtual Reality - End Stage Renal Disease on Dialysis
Not applicableNot yet recruitingSir Mortimer B. Davis - Jewish General Hospital642026-06-012026-04-20
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
AP306 75 mg BID, AP306 125 mg BID, AP306 150 mg BID - Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2RecruitingR1 Therapeutics1682026-06-012026-08-26
A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension
CHM intervention group, No CHM treatment - End Stage Renal Disease on Dialysis, Intradialytic Hypotension
Phase 2 / Phase 3Not yet recruitingChang Gung Memorial Hospital1002026-02-022026-02-25
Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients
C-Reactive Protein (CRP) Test, D-dimer Test, Electrocardiogram (ECG) - End Stage Renal Disease on Dialysis
Not yet recruitingAssiut University1002025-11-012025-08-19
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
Fight Fatigue, Attention Control - End Stage Renal Disease on Dialysis
Not applicableRecruitingUniversity of Illinois at Chicago402025-09-022026-09-02
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
pHA130 Hemoadsorption + High-Flux Hemodialysis - End Stage Renal Disease on Dialysis
Not applicableRecruitingPeking University People's Hospital342025-07-012025-08-08
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney, Kidney Transplantation with Standard Care - End-Stage Renal Disease, End Stage Renal Disease on Dialysis
Phase 1 / Phase 2RecruitingAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC902025-06-012025-07-08
Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
pHA130 hemoperfusion device, HD/HDF, HA130 hemoperfusion device - End Stage Renal Disease on Dialysis
CompletedXinhua Hospital, Shanghai Jiao Tong University School of Medicine1092025-05-122026-09-10
Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease
Coated Aldehyde Oxystarch - End Stage Renal Disease on Dialysis
Not applicableRecruitingPeking University People's Hospital302025-04-212026-06-17
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
Moda-flx Hemodialysis System - End Stage Renal Disease, End Stage Renal Disease on Dialysis
Not applicableCompletedDiality Inc.122024-12-092025-06-22
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
endoAVF, surgAVF - End Stage Renal Disease on Dialysis
Not applicableActive not recruitingUniversity of California, Los Angeles902024-11-202026-08-10
Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis
Electrical Impedance Tomography (EIT) Monitoring - Arteriovenous Graft Thrombosis, End Stage Renal Disease on Dialysis
RecruitingFirst Affiliated Hospital of Wannan Medical College202024-10-242026-05-29
Intradialytic Kinetics of Cardiac Biomarkers During Hemodialysis and Hemodiafiltration
High-flux hemodialysis, Post-dilution hemodiafiltration - End Stage Renal Disease on Dialysis
Not applicableCompletedAalborg University Hospital262024-09-122025-10-07
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
Empagliflozin 10 MG - End Stage Renal Disease on Dialysis, Peritoneal Dialysis Complication
Phase 2RecruitingChinese University of Hong Kong482024-07-292026-10-22
Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
Vitamin b12 measure - End Stage Renal Disease on Dialysis, Vitamin B 12 Deficiency
UnknownAssiut University602024-07-052024-06-06
Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
Empagliflozin 25 MG, Placebo - Heart Failure with Reduced Ejection Fraction, End Stage Renal Disease on Dialysis
Phase 4RecruitingNational Taiwan University Hospital952024-03-132024-12-13
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Empagliflozin 25 MG, Placebo - Heart Failure With Preserved Ejection Fraction, End Stage Renal Disease on Dialysis
Phase 4RecruitingNational Taiwan University Hospital1502024-03-052024-12-16
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
GORE® ACUSEAL Vascular Graft - Chronic Kidney Diseases, End Stage Renal Disease on Dialysis
RecruitingW.L.Gore & Associates722024-01-122026-08-13
Pulmonary Function Tests in Children and Adolescents With End Stage Renal Disease On Regular Hemodialysis
End Stage Renal Disease on Dialysis
UnknownAssiut University402024-01-012023-10-31

Showing 20 of 70. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (16)  ·  Renal Insufficiency, Chronic (5)  ·  Hyperphosphatemia (2)  ·  Kidney Diseases (2)  ·  Motor Activity (2)  ·  Renal Insufficiency (2)  ·  Acidosis (1)  ·  Acute Kidney Injury (1)  ·  Arrhythmias, Cardiac (1)  ·  Arteriovenous Fistula (1)  ·  Carcinoma, Renal Cell (1)  ·  Cardiovascular Diseases (1)  ·  Constipation (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Female Urogenital Diseases (22)  ·  Female Urogenital Diseases and Pregnancy Complications (22)  ·  Male Urogenital Diseases (22)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Urogenital Diseases (22)  ·  Urologic Diseases (22)  ·  Kidney Diseases (20)  ·  Pathologic Processes (20)  ·  Chronic Disease (19)  ·  Disease Attributes (19)  ·  Renal Insufficiency (18)  ·  Renal Insufficiency, Chronic (14)  ·  Nutritional and Metabolic Diseases (6)  ·  Cardiovascular Diseases (5)  ·  Metabolic Diseases (5)

Interventions

empagliflozin (4)  ·  Motivational Interviewing (2)  ·  BID protein, human (1)  ·  Bandages (1)  ·  Chlorthalidone (1)  ·  Chromogranins (1)  ·  Colchicine (1)  ·  Control Groups (1)  ·  Diet Therapy (1)  ·  Dietary Supplements (1)  ·  Electrocardiography (1)  ·  Furosemide (1)  ·  Kidney Transplantation (1)  ·  Nutrition Assessment (1)  ·  Observation (1)

Sponsors

Assiut University (3)  ·  Cardenal Herrera University (3)  ·  Universitas Indonesia (3)  ·  Ain Shams University (2)  ·  Far Eastern Memorial Hospital (2)  ·  National Taiwan University Hospital (2)  ·  Outset Medical (2)  ·  Peking University People's Hospital (2)  ·  RenJi Hospital (2)  ·  Taylor's University (2)  ·  Vanderbilt University Medical Center (2)  ·  AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC (1)  ·  Aalborg University Hospital (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari (1)

Countries

United States (15)  ·  China (11)  ·  Taiwan (7)  ·  United Kingdom (5)  ·  Spain (4)  ·  Canada (3)  ·  Denmark (3)  ·  Egypt (3)  ·  Greece (2)  ·  Italy (2)  ·  Singapore (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)

Top investigators

Chih-Cheng Wu, MD. PhD (2)  ·  Ebele M Umeukeje, MD, MPH (2)  ·  Tilakavati Karupaiah, PhD (2)  ·  Wan-Chuan Tsai, M.D., Ph.D. (2)  ·  Ai Peng, MD, PhD (1)  ·  Aida Lydia, MD, PhD (1)  ·  Alex Gold, MD (1)  ·  Allen Yan Lun Liu (1)  ·  Alvin Moss, MD (1)  ·  Aphichat Chatkrailert, M.D. (1)  ·  Branko Braam, MD/Ph.D. (1)  ·  Changlin Mei, M.D. (1)  ·  Cheuk Chun Szeto, MD, FRCP (1)  ·  Chi-yuan Hsu, MD (1)

Results publications

PMID 40855136, PMID 15380917, PMID 18824874, PMID 19153263, PMID 19210277, PMID 19539185, PMID 21546884, PMID 21727925, PMID 23411788, PMID 24089155, PMID 24825343, PMID 25007166, PMID 25171342, PMID 25859371, PMID 27528215, PMID 27742823, PMID 28337715, PMID 28398983, PMID 29064141, PMID 29672745, PMID 30805639, PMID 31302884, PMID 31661683, PMID 32706698, PMID 33135208, PMID 33391741, PMID 33564444, PMID 33610770, PMID 33891656, PMID 34139470, PMID 34548369, PMID 34977109, PMID 35869437, PMID 36104084, PMID 37120127, PMID 37326323, PMID 37889550, PMID 37890966, PMID 38082293, PMID 38123748, PMID 38189095, PMID 38273436, PMID 38899545, PMID 39827429, PMID 40019498, PMID 40038667, PMID 41545041, PMID 41952779, PMID 42237221, PMID 8856214

NIH funding

2019 (1), R01DK123104 (1), R01DK132422 (1), R01DK133530 (1), R03DK129626 (1), R34AT012770 (1)